21 CFR 358.301
§ 358.301 Scope.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 358.301, § 358.301 Scope, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/86741
- Permanent ID
ys:prov:86741@1- SHA-256
ac748b9a2f1827b43781ba635e27e26303d5629e869ffbfe0e9b6864d7c415c1
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) An over-the-counter ingrown toenail relief drug product in a form suitable for topical administration is generally recognized as safe and effective and is not misbranded if it meets each condition in this subpart and each general condition established in § 330.1 of this chapter.
(b) References in this subpart to regulatory sections of the Code of Federal Regulations are to chapter 1 of title 21 unless otherwise noted.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.